Model bests IPSS-R for predicting survival, risk for AML in myelodysplastic syndromeDecember 3, 2018AMLHematology
TOURMALINE-MM3: Ixazomib improves PFS after myeloma transplantDecember 2, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Beat AML trial delivers genomic results in 7 daysDecember 2, 2018AMLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Gut bacteria influence HCT outcomesDecember 2, 2018Leukemia, Myelodysplasia, TransplantationOncologyHematology
ELIANA update: Tisagenlecleucel responses durable in r/r B-cell ALLDecember 2, 2018Leukemia, Myelodysplasia, Transplantation
MEDALIST: Erythroid maturation agent reduced transfusion burden in MDSDecember 1, 2018Leukemia, Myelodysplasia, Transplantation
FLYER: Four cycles of R-CHOP as good as six in low-risk DLBCLDecember 1, 2018Lymphoma & Plasma Cell Disorders
Stem cell transplant after CAR T cells may reduce B-ALL relapse riskDecember 1, 2018Leukemia, Myelodysplasia, Transplantation
Novel conditioning and familial haploidentical SCT well tolerated, cured 90% of patientsDecember 1, 2018Hematology
FLYER: R-CHOP 4 safer, as effective for low-risk DLBCL patients under 60December 1, 2018Lymphoma & Plasma Cell Disorders
